No.CD8-H5224) is more than 95%, with a molecular weight of around 35-45 kDa – verified by SEC-MALS. Image Credit: ACROBiosystems High bioactivity of Human CD38 (Cat. No. CD8-H5224) is confirmed ...

By clarifying T cell markers (e.g. KLRG1, CD38, HLA-DR), and the timeline for when CD8+ T cells arise in the blood after vaccination, the new work may enable clinical teams to tell which patients ...

Aberrant NK cells (red) were positive for CD2, CD16 (dim), CD38, and CD56 (bright) and negative for surface CD3, CD4, CD5, CD7, and CD8. Normal NK cells (cyan), T cells (green), and B cells (blue ...

Patients who were hospitalized had MAIT cells that demonstrated a more activated phenotype with higher CD38 expression and MAIT cells and conventional CD8 T cells did not differ between ...

Treatment with CM313, a novel anti-CD38 monoclonal antibody, can result in targeted clearance of CD38-positive cells, including plasma cells. We conducted a phase 1–2, open-label study to ...

Despite initial clinical data showing efficacy, Genmab has decided to discontinue further clinical development of ...

(a) Effector Tregs (eTregs) most strongly affect CD8-EM cells and B-plasma cells ... and another expressing CD38 and CCR7 - a pattern seen in severe viral infections. (e) Ranks different Treg ...